News & Events

Press Releases

Press Releases

Date Title
2019-06-25 TLC Announces Development and License Agreement with Birdie Biopharmaceuticals for NanoX™ Immunotherapy Product
2019-06-14 TLC Announces Part 1 Analysis of TLC590 Phase II Clinical Trial for Postsurgical Pain Management following Bunionectomy
2019-06-12 TLC Presents New Pharmacokinetic and Toxicokinetic Data on TLC599 Following Intra-articular Injection in Dogs at EULAR 2019
2019-05-08 TLC Reports First Quarter of 2019 Financial Results and Provides Business Update
2019-05-06 TLC Highlights Data Presentations on Lead Product Candidate TLC599 at Osteoarthritis Research Society International (OARSI) 2019 World Congress
2019-05-02 TLC Earns Highest Ranks in Corporate Governance Evaluation for 5th Consecutive Year
2019-04-22 TLC to Present at Upcoming Conferences
2019-04-15 TLC Announces Positive End-of-Phase II Meeting with FDA for TLC599 in Knee Osteoarthritis
2019-04-08 TLC Announces Full Enrollment in Part 1 of Phase II Trial of TLC590 for Postsurgical Pain Management following Bunionectomy
2019-04-01 TLC Reports Fourth Quarter and Full Year 2018 Financial Results and Business Update
2019-03-25 TLC to Present High-Scoring Scientific Abstracts on Acute Pain through Moderated Sessions at ASRA Spring 2019
2019-03-18 TLC Announces First Patient Dosed in Phase II Trial of TLC590 for Postsurgical Pain Management following Bunionectomy
2019-03-11 TLC Reports Positive Top-Line Results from Phase I/II Clinical Trial of TLC590 for Postsurgical Pain
2019-03-03 TLC and 3SBio Form Exclusive Partnership to Commercialize Two NanoX™ Products in Mainland China
2019-01-25 TLC Appoints George Spencer-Green, MD, MS, as Chief Medical Officer
2019-01-22 EMA Grants Orphan Drug Designation to TLC178 for the Treatment of Soft Tissue Sarcoma
2019-01-02 Taiwan Liposome Company to Attend 37th Annual J.P. Morgan Healthcare conference